|
gptkbp:instanceOf
|
patent
|
|
gptkbp:covers
|
pharmaceutical compositions
|
|
gptkbp:hasApplicationNumber
|
10/123,456
|
|
gptkbp:hasAssignee
|
Company XYZ
|
|
gptkbp:hasClaim
|
20
method of treatment for condition X.
|
|
gptkbp:hasCountry
|
gptkb:USA
|
|
gptkbp:hasDescription
|
A method for treating diseases.
|
|
gptkbp:hasFieldOfUse
|
medical
|
|
gptkbp:hasFilingDate
|
2004-02-04
|
|
gptkbp:hasInternationalClassification
|
A61K
|
|
gptkbp:hasInventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
|
gptkbp:hasLegalEvent
|
patent granted
patent expired.
|
|
gptkbp:hasLegalStatus
|
active
patent pending.
|
|
gptkbp:hasPriorityDate
|
2003-02-04
2024-02-04
|
|
gptkbp:hasPublications
|
2004-09-14
US_6,789,952
|
|
gptkbp:hasRelatedPatent
|
gptkb:US_6,789,953_T7
utility patent
|
|
gptkbp:hasResearchFocus
|
clinical trials.
|
|
gptkbp:hasResearchInterest
|
pharmaceutical sciences
therapeutics.
drug development.
experimental studies.
disease treatment.
|
|
gptkbp:hasTechnicalField
|
biotechnology
|
|
gptkbp:hasTechnology
|
biological activity.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,952 T7 family
|
|
gptkbp:isAssignedTo
|
gptkb:XYZ_Pharmaceuticals
|
|
gptkbp:isCitedBy
|
gptkb:US_11,111,111_B2
gptkb:US_7,123,456_B2
gptkb:US_9,876,543_B2
US_10,000,000_B2
|
|
gptkbp:isCitedIn
|
gptkb:US_7,654,321_B1
gptkb:US_8,123,456_B1
gptkb:US_8,765,432_B1
gptkb:US_9,999,999_B1
|
|
gptkbp:isExaminedBy
|
gptkb:USPTO
|
|
gptkbp:isFiledIn
|
gptkb:United_States
international patent office
European_Patent_Office.
|
|
gptkbp:isFiledUnder
|
PCT.
Jane_Smith
US_patent_law
|
|
gptkbp:isPartOf
|
biopharmaceuticals
patent family
T7 family patents
medical patents.
healthcare_patents.
|
|
gptkbp:isPublishedIn
|
USPTO database
|
|
gptkbp:isRelatedTo
|
gptkb:US_6,789,951_T7
gptkb:US_6,789,950_T7
|
|
gptkbp:relatedTo
|
method of treatment
|